Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms

[1]  H. Feng,et al.  Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. , 2003, Blood.

[2]  Freda K. Stevenson,et al.  Critical Components of a DNA Fusion Vaccine Able to Induce Protective Cytotoxic T Cells Against a Single Epitope of a Tumor Antigen1 , 2002, The Journal of Immunology.

[3]  G. Mufti,et al.  Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell–leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination , 2002, Cancer Immunology, Immunotherapy.

[4]  S. Pal,et al.  Curcumin induces apoptosis in human breast cancer cells through p53‐dependent Bax induction , 2002, FEBS letters.

[5]  B. Aggarwal,et al.  Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.

[6]  S. Lin-Shiau,et al.  Mechanisms of cancer chemoprevention by curcumin. , 2001, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[7]  W. You,et al.  Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin , 1999, Breast Cancer Research and Treatment.

[8]  S. Jee,et al.  Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. , 1998, The Journal of investigative dermatology.

[9]  J. Kapp,et al.  Antigen Is Required for the Activation of Effector Activities, whereas Interleukin 2 Is Required for the Maintenance of Memory in Ovalbumin-specific, CD8+ Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.

[10]  M. Pfreundschuh,et al.  Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Coulie,et al.  Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[12]  L. Kwak,et al.  Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. , 2002, Haematologica.

[13]  B. Aggarwal,et al.  Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. , 2002, Carcinogenesis.

[14]  Jen-kun Lin,et al.  Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. , 1996, Nutrition and cancer.

[15]  L. Clarke,et al.  A colony bank containing synthetic Col El hybrid plasmids representative of the entire E. coli genome. 1976. , 1992, Biotechnology.

[16]  Najman,et al.  NB 4 , a Maturation Inducible Cell Line With t ( 15 ; 17 ) Marker Isolated From a Human Acute Promyelocytic Leukemia ( M 3 ) , 2022 .